The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Irritable Bowel Syndrome with Constipation Drugs-Global Market Insights and Sales Trends 2024
Synopsis
The symptoms of IBS-C include abdominal pain and discomfort, along with changes in bowel function. Bloating and/or gas also may happen. Changes in bowel function may include straining, infrequent stools, hard or lumpy stools, and/or a feeling that the bowel does not empty completely.
The global Irritable Bowel Syndrome with Constipation Drugs market size is expected to reach US$ 3547.7 million by 2029, growing at a CAGR of 12.8% from 2023 to 2029. The market is mainly driven by the significant applications of Irritable Bowel Syndrome with Constipation Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Irritable Bowel Syndrome with Constipation Drugs market. Lubiprostone, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Linaclotide segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Irritable Bowel Syndrome with Constipation Drugs market, driven by demand from China, the second largest economy with some signs of stabilising, the Irritable Bowel Syndrome with Constipation Drugs market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Irritable Bowel Syndrome with Constipation Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Irritable Bowel Syndrome with Constipation Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Irritable Bowel Syndrome with Constipation Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Irritable Bowel Syndrome with Constipation Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Irritable Bowel Syndrome with Constipation Drugs covered in this report include Nestle, Abbot Laboratories, Synergy Pharmaceuticals, Sucampo Pharmaceuticals, Novartis, Astellas Pharmaceuticals, Mallinckrodt, Bausch Health Companies and Ardelyx, etc.
The global Irritable Bowel Syndrome with Constipation Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Nestle
Abbot Laboratories
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Novartis
Astellas Pharmaceuticals
Mallinckrodt
Bausch Health Companies
Ardelyx
Ironwood Pharmaceuticals
Takeda Pharmaceutical
Global Irritable Bowel Syndrome with Constipation Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Irritable Bowel Syndrome with Constipation Drugs market, Segment by Type:
Lubiprostone
Linaclotide
Stimulant Laxatives
Osmotic Laxatives
Others
Global Irritable Bowel Syndrome with Constipation Drugs market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Irritable Bowel Syndrome with Constipation Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The symptoms of IBS-C include abdominal pain and discomfort, along with changes in bowel function. Bloating and/or gas also may happen. Changes in bowel function may include straining, infrequent stools, hard or lumpy stools, and/or a feeling that the bowel does not empty completely.
The global Irritable Bowel Syndrome with Constipation Drugs market size is expected to reach US$ 3547.7 million by 2029, growing at a CAGR of 12.8% from 2023 to 2029. The market is mainly driven by the significant applications of Irritable Bowel Syndrome with Constipation Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Irritable Bowel Syndrome with Constipation Drugs market. Lubiprostone, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Linaclotide segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Irritable Bowel Syndrome with Constipation Drugs market, driven by demand from China, the second largest economy with some signs of stabilising, the Irritable Bowel Syndrome with Constipation Drugs market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Irritable Bowel Syndrome with Constipation Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Irritable Bowel Syndrome with Constipation Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Irritable Bowel Syndrome with Constipation Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Irritable Bowel Syndrome with Constipation Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Irritable Bowel Syndrome with Constipation Drugs covered in this report include Nestle, Abbot Laboratories, Synergy Pharmaceuticals, Sucampo Pharmaceuticals, Novartis, Astellas Pharmaceuticals, Mallinckrodt, Bausch Health Companies and Ardelyx, etc.
The global Irritable Bowel Syndrome with Constipation Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Nestle
Abbot Laboratories
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Novartis
Astellas Pharmaceuticals
Mallinckrodt
Bausch Health Companies
Ardelyx
Ironwood Pharmaceuticals
Takeda Pharmaceutical
Global Irritable Bowel Syndrome with Constipation Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Irritable Bowel Syndrome with Constipation Drugs market, Segment by Type:
Lubiprostone
Linaclotide
Stimulant Laxatives
Osmotic Laxatives
Others
Global Irritable Bowel Syndrome with Constipation Drugs market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Irritable Bowel Syndrome with Constipation Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Irritable Bowel Syndrome with Constipation Drugs
1.1 Irritable Bowel Syndrome with Constipation Drugs Market Overview
1.1.1 Irritable Bowel Syndrome with Constipation Drugs Product Scope
1.1.2 Irritable Bowel Syndrome with Constipation Drugs Market Status and Outlook
1.2 Global Irritable Bowel Syndrome with Constipation Drugs Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Irritable Bowel Syndrome with Constipation Drugs Market Size by Region (2018-2029)
1.4 Global Irritable Bowel Syndrome with Constipation Drugs Historic Market Size by Region (2018-2023)
1.5 Global Irritable Bowel Syndrome with Constipation Drugs Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Irritable Bowel Syndrome with Constipation Drugs Market Size (2018-2029)
1.6.1 North America Irritable Bowel Syndrome with Constipation Drugs Market Size (2018-2029)
1.6.2 Europe Irritable Bowel Syndrome with Constipation Drugs Market Size (2018-2029)
1.6.3 Asia-Pacific Irritable Bowel Syndrome with Constipation Drugs Market Size (2018-2029)
1.6.4 Latin America Irritable Bowel Syndrome with Constipation Drugs Market Size (2018-2029)
1.6.5 Middle East & Africa Irritable Bowel Syndrome with Constipation Drugs Market Size (2018-2029)
2 Irritable Bowel Syndrome with Constipation Drugs Market by Type
2.1 Introduction
2.1.1 Lubiprostone
2.1.2 Linaclotide
2.1.3 Stimulant Laxatives
2.1.4 Osmotic Laxatives
2.1.5 Others
2.2 Global Irritable Bowel Syndrome with Constipation Drugs Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Irritable Bowel Syndrome with Constipation Drugs Historic Market Size by Type (2018-2023)
2.2.2 Global Irritable Bowel Syndrome with Constipation Drugs Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Irritable Bowel Syndrome with Constipation Drugs Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Irritable Bowel Syndrome with Constipation Drugs Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Irritable Bowel Syndrome with Constipation Drugs Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Irritable Bowel Syndrome with Constipation Drugs Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Irritable Bowel Syndrome with Constipation Drugs Revenue Breakdown by Type (2018-2029)
3 Irritable Bowel Syndrome with Constipation Drugs Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Irritable Bowel Syndrome with Constipation Drugs Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Irritable Bowel Syndrome with Constipation Drugs Historic Market Size by Application (2018-2023)
3.2.2 Global Irritable Bowel Syndrome with Constipation Drugs Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Irritable Bowel Syndrome with Constipation Drugs Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Irritable Bowel Syndrome with Constipation Drugs Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Irritable Bowel Syndrome with Constipation Drugs Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Irritable Bowel Syndrome with Constipation Drugs Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Irritable Bowel Syndrome with Constipation Drugs Revenue Breakdown by Application (2018-2029)
4 Irritable Bowel Syndrome with Constipation Drugs Competition Analysis by Players
4.1 Global Irritable Bowel Syndrome with Constipation Drugs Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome with Constipation Drugs as of 2022)
4.3 Date of Key Players Enter into Irritable Bowel Syndrome with Constipation Drugs Market
4.4 Global Top Players Irritable Bowel Syndrome with Constipation Drugs Headquarters and Area Served
4.5 Key Players Irritable Bowel Syndrome with Constipation Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Irritable Bowel Syndrome with Constipation Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Nestle
5.1.1 Nestle Profile
5.1.2 Nestle Main Business
5.1.3 Nestle Irritable Bowel Syndrome with Constipation Drugs Products, Services and Solutions
5.1.4 Nestle Irritable Bowel Syndrome with Constipation Drugs Revenue (US$ Million) & (2018-2023)
5.1.5 Nestle Recent Developments
5.2 Abbot Laboratories
5.2.1 Abbot Laboratories Profile
5.2.2 Abbot Laboratories Main Business
5.2.3 Abbot Laboratories Irritable Bowel Syndrome with Constipation Drugs Products, Services and Solutions
5.2.4 Abbot Laboratories Irritable Bowel Syndrome with Constipation Drugs Revenue (US$ Million) & (2018-2023)
5.2.5 Abbot Laboratories Recent Developments
5.3 Synergy Pharmaceuticals
5.3.1 Synergy Pharmaceuticals Profile
5.3.2 Synergy Pharmaceuticals Main Business
5.3.3 Synergy Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Products, Services and Solutions
5.3.4 Synergy Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Revenue (US$ Million) & (2018-2023)
5.3.5 Sucampo Pharmaceuticals Recent Developments
5.4 Sucampo Pharmaceuticals
5.4.1 Sucampo Pharmaceuticals Profile
5.4.2 Sucampo Pharmaceuticals Main Business
5.4.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Products, Services and Solutions
5.4.4 Sucampo Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Revenue (US$ Million) & (2018-2023)
5.4.5 Sucampo Pharmaceuticals Recent Developments
5.5 Novartis
5.5.1 Novartis Profile
5.5.2 Novartis Main Business
5.5.3 Novartis Irritable Bowel Syndrome with Constipation Drugs Products, Services and Solutions
5.5.4 Novartis Irritable Bowel Syndrome with Constipation Drugs Revenue (US$ Million) & (2018-2023)
5.5.5 Novartis Recent Developments
5.6 Astellas Pharmaceuticals
5.6.1 Astellas Pharmaceuticals Profile
5.6.2 Astellas Pharmaceuticals Main Business
5.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Products, Services and Solutions
5.6.4 Astellas Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Revenue (US$ Million) & (2018-2023)
5.6.5 Astellas Pharmaceuticals Recent Developments
5.7 Mallinckrodt
5.7.1 Mallinckrodt Profile
5.7.2 Mallinckrodt Main Business
5.7.3 Mallinckrodt Irritable Bowel Syndrome with Constipation Drugs Products, Services and Solutions
5.7.4 Mallinckrodt Irritable Bowel Syndrome with Constipation Drugs Revenue (US$ Million) & (2018-2023)
5.7.5 Mallinckrodt Recent Developments
5.8 Bausch Health Companies
5.8.1 Bausch Health Companies Profile
5.8.2 Bausch Health Companies Main Business
5.8.3 Bausch Health Companies Irritable Bowel Syndrome with Constipation Drugs Products, Services and Solutions
5.8.4 Bausch Health Companies Irritable Bowel Syndrome with Constipation Drugs Revenue (US$ Million) & (2018-2023)
5.8.5 Bausch Health Companies Recent Developments
5.9 Ardelyx
5.9.1 Ardelyx Profile
5.9.2 Ardelyx Main Business
5.9.3 Ardelyx Irritable Bowel Syndrome with Constipation Drugs Products, Services and Solutions
5.9.4 Ardelyx Irritable Bowel Syndrome with Constipation Drugs Revenue (US$ Million) & (2018-2023)
5.9.5 Ardelyx Recent Developments
5.10 Ironwood Pharmaceuticals
5.10.1 Ironwood Pharmaceuticals Profile
5.10.2 Ironwood Pharmaceuticals Main Business
5.10.3 Ironwood Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Products, Services and Solutions
5.10.4 Ironwood Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Revenue (US$ Million) & (2018-2023)
5.10.5 Ironwood Pharmaceuticals Recent Developments
5.11 Takeda Pharmaceutical
5.11.1 Takeda Pharmaceutical Profile
5.11.2 Takeda Pharmaceutical Main Business
5.11.3 Takeda Pharmaceutical Irritable Bowel Syndrome with Constipation Drugs Products, Services and Solutions
5.11.4 Takeda Pharmaceutical Irritable Bowel Syndrome with Constipation Drugs Revenue (US$ Million) & (2018-2023)
5.11.5 Takeda Pharmaceutical Recent Developments
6 North America
6.1 North America Irritable Bowel Syndrome with Constipation Drugs Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Irritable Bowel Syndrome with Constipation Drugs Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Irritable Bowel Syndrome with Constipation Drugs Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Irritable Bowel Syndrome with Constipation Drugs Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Irritable Bowel Syndrome with Constipation Drugs Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Irritable Bowel Syndrome with Constipation Drugs Market Dynamics
11.1 Irritable Bowel Syndrome with Constipation Drugs Industry Trends
11.2 Irritable Bowel Syndrome with Constipation Drugs Market Drivers
11.3 Irritable Bowel Syndrome with Constipation Drugs Market Challenges
11.4 Irritable Bowel Syndrome with Constipation Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
